CanSino Biologics Inc. (OTCMKTS:CASBF) Sees Large Growth in Short Interest

CanSino Biologics Inc. (OTCMKTS:CASBF) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 14,800 shares, a growth of 37.0% from the November 15th total of 10,800 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 148.0 days.

CanSino Biologics Price Performance

Shares of OTCMKTS CASBF remained flat at C$4.35 during midday trading on Friday. The stock’s 50-day simple moving average is C$3.74 and its two-hundred day simple moving average is C$2.90. CanSino Biologics has a 12 month low of C$1.86 and a 12 month high of C$4.35.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.